FDA Inspection 1148699 — Kenneth R. Kenyon, M.D.

Kenneth R. Kenyon, M.D. — FEI 3018002077

The FDA completed an inspection of Kenneth R. Kenyon, M.D. on July 26, 2021 in Andover, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 26, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Andover, MA (United States)

Additional Details

Clinical Investigator (CI)